| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ian G McKeith, Elise Rowan, Kristina Askew, Anitha Naidu, Louise Allan, Nicky Barnett, Debbie Lett, Urs P Mosimann, David Burn, John T O'Brie. More severe functional impairment in dementia with lewy bodies than Alzheimer disease is related to extrapyramidal motor dysfunction. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. vol 14. issue 7. 2006-09-01. PMID:16816011. |
the objective of this study was to compare functional impairments in dementia with lewy bodies (dlb) and alzheimer disease (ad) and their relationship with motor and neuropsychiatric symptoms. |
2006-09-01 |
2023-08-12 |
Not clear |
| Akiko Kobayashi, Chiaki Kawanishi, Takehiko Matsumura, Daiji Kato, Ryoko Furukawa, Ikuko Kishida, Yoshio Hirayas. Quetiapine-induced neuroleptic malignant syndrome in dementia with Lewy bodies: a case report. Progress in neuro-psychopharmacology & biological psychiatry. vol 30. issue 6. 2006-08-23. PMID:16682107. |
patients with dementia with lewy bodies (dlb) are particularly vulnerable to adverse effects of neuroleptics; this sensitivity is included among the clinical diagnostic criteria for dlb. |
2006-08-23 |
2023-08-12 |
Not clear |
| Kenichi Kashihara, Manabu Ohno, Sanami Kawada, Yoshihiro Okumur. Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. vol 47. issue 7. 2006-08-16. PMID:16818943. |
the purpose of this study was to investigate myocardial uptake of 123i-metaiodobenzylguanidine (mibg) in patients with pure autonomic failure (paf), which has pathologic features in common with idiopathic parkinson's disease (ipd) and dementia with lewy bodies (dlb). |
2006-08-16 |
2023-08-12 |
Not clear |
| Ryoko Yamamoto, Eizo Iseki, Norio Murayama, Michiko Minegishi, Wami Marui, Takashi Togo, Omi Katsuse, Masanori Kato, Takeshi Iwatsubo, Kenji Kosaka, Heii Ara. Investigation of Lewy pathology in the visual pathway of brains of dementia with Lewy bodies. Journal of the neurological sciences. vol 246. issue 1-2. 2006-08-10. PMID:16624323. |
we examined 19 autopsied cases of dementia with lewy bodies (dlb) using pathological and alpha-synuclein-immunohistochemical methods, and investigated lewy pathology in the primary visual pathway (lateral geniculate body and brodmann's area 17), secondary visual pathway (pulvinar, brodmann's areas 18 and 19, and inferior temporal cortex), amygdala and substantia nigra, to clarify the relationship between visual misidentification and lewy pathology in the visual pathway. |
2006-08-10 |
2023-08-12 |
Not clear |
| Carmen Cristea Janvin, Jan Petter Larsen, David P Salmon, Douglas Galasko, Kenneth Hugdahl, Dag Aarslan. Cognitive profiles of individual patients with Parkinson's disease and dementia: comparison with dementia with lewy bodies and Alzheimer's disease. Movement disorders : official journal of the Movement Disorder Society. vol 21. issue 3. 2006-08-03. PMID:16211595. |
we describe the pattern of cognitive profiles within a community-based sample of patients with parkinson's disease (pd) and dementia (pdd) using cluster analyses, and compare the results with data from patients with alzheimer's disease (ad) and dementia with lewy bodies (dlb). |
2006-08-03 |
2023-08-12 |
Not clear |
| Justin Sauer, Dominic H ffytche, Clive Ballard, Richard G Brown, Robert Howar. Differences between Alzheimer's disease and dementia with Lewy bodies: an fMRI study of task-related brain activity. Brain : a journal of neurology. vol 129. issue Pt 7. 2006-08-03. PMID:16670180. |
we investigated whether previously reported differences between alzheimer's disease and dementia with lewy bodies (dlb) in resting occipital activity lead to activation differences within functionally specialized visual cortical areas and deactivation differences in the default network. |
2006-08-03 |
2023-08-12 |
Not clear |
| Marta Barrachina, Esther Castaño, Esther Dalfó, Tamara Maes, Carlos Buesa, Isidro Ferre. Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies. Neurobiology of disease. vol 22. issue 2. 2006-07-25. PMID:16380264. |
parkinson disease (pd) and dementia with lewy bodies (dlb) are characterized by the accumulation of abnormal alpha-synuclein and ubiquitin in protein aggregates conforming lewy bodies and lewy neurites. |
2006-07-25 |
2023-08-12 |
Not clear |
| M Yoshita, J Taki, K Yokoyama, M Noguchi-Shinohara, Y Matsumoto, K Nakajima, M Yamad. Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD. Neurology. vol 66. issue 12. 2006-07-19. PMID:16801649. |
to evaluate the diagnostic reliability of cardiac iodine-123 metaiodobenzylguanidine ((123)i-mibg) radioactivity in discriminating dementia with lewy bodies (dlb) from alzheimer disease (ad) regardless of parkinsonism. |
2006-07-19 |
2023-08-12 |
Not clear |
| S Zaja-Milatovic, C D Keene, K S Montine, J B Leverenz, D Tsuang, T J Montin. Selective dendritic degeneration of medium spiny neurons in dementia with Lewy bodies. Neurology. vol 66. issue 10. 2006-06-28. PMID:16717229. |
dementia with lewy bodies (dlb) is the second most common form of dementia and shows more severely impaired performance on tests of executive functions compared to alzheimer disease. |
2006-06-28 |
2023-08-12 |
Not clear |
| Laura Bonanni, Astrid Thomas, Marco Onofr. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. vol 66. issue 9. 2006-06-12. PMID:16682691. |
diagnosis and management of dementia with lewy bodies: third report of the dlb consortium. |
2006-06-12 |
2023-08-12 |
Not clear |
| Satoru Mori, Etsuro Mori, Eizo Iseki, Kenji Kosak. Efficacy and safety of donepezil in patients with dementia with Lewy bodies: preliminary findings from an open-label study. Psychiatry and clinical neurosciences. vol 60. issue 2. 2006-06-06. PMID:16594943. |
the objectives of the present study were first to determine the feasibility of conducting a randomized clinical trial of 5 mg/day donepezil in patients with mild to moderate dementia with lewy bodies (dlb) and second, to obtain preliminary data of possible intervention effects. |
2006-06-06 |
2023-08-12 |
Not clear |
| Satoru Mori, Etsuro Mori, Eizo Iseki, Kenji Kosak. Efficacy and safety of donepezil in patients with dementia with Lewy bodies: preliminary findings from an open-label study. Psychiatry and clinical neurosciences. vol 60. issue 2. 2006-06-06. PMID:16594943. |
donepezil is expected to be therapeutically useful and safe in treating dlb patients, indicating marked improvements in behavioral and psychological symptoms of dementia (bpsd) rather than in cognitive deficit, without deteriorating parkinsonism. |
2006-06-06 |
2023-08-12 |
Not clear |
| V Deramecourt, S Bombois, C-A Maurage, A Ghestem, H Drobecq, E Vanmechelen, F Lebert, F Pasquier, A Delacourt. Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies. Journal of neuropathology and experimental neurology. vol 65. issue 3. 2006-06-05. PMID:16651889. |
the primary feature of dementia with lewy bodies (dlb) is the aggregation of alpha-synuclein into characteristic lesions: lewy bodies (lbs) and lewy neurites. |
2006-06-05 |
2023-08-12 |
Not clear |
| Mirko Bibl, Brit Mollenhauer, Hermann Esselmann, Piotr Lewczuk, Hans-Wolfgang Klafki, Katrin Sparbier, Alexandr Smirnov, Lukas Cepek, Claudia Trenkwalder, Eckart Rüther, Johannes Kornhuber, Markus Otto, Jens Wiltfan. CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia. Brain : a journal of neurology. vol 129. issue Pt 5. 2006-05-31. PMID:16600985. |
amyloid plaques deposited in the brain of patients suffering from alzheimer's disease, dementia with lewy bodies (dlb) and parkinson's disease dementia (pdd) mainly consist of carboxy-terminally elongated forms of amyloid-beta (abeta) peptides, such as abeta1-42. |
2006-05-31 |
2023-08-12 |
human |
| D J Burn, E N Rowan, L M Allan, S Molloy, J T O'Brien, I G McKeit. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. Journal of neurology, neurosurgery, and psychiatry. vol 77. issue 5. 2006-05-30. PMID:16614017. |
a previous cross sectional study found over-representation of a postural instability gait difficulty (pigd) motor subtype in parkinson's disease patients with dementia (pdd) and dementia with lewy bodies (dlb), compared with parkinson's disease (pd). |
2006-05-30 |
2023-08-12 |
Not clear |
| Sebastiaan Engelborghs, Karen Maertens, Ellen Vloeberghs, Tony Aerts, Nore Somers, Peter Mariën, Peter P De Dey. Neuropsychological and behavioural correlates of CSF biomarkers in dementia. Neurochemistry international. vol 48. issue 4. 2006-05-26. PMID:16434124. |
patients with probable alzheimer's disease (ad) (n=201), ad with cerebrovascular disease (cvd) (ad+cvd) (n=33), frontotemporal dementia (ftd) (n=27), dementia with lewy bodies (dlb) (n=22) and healthy controls (n=148) were included. |
2006-05-26 |
2023-08-12 |
Not clear |
| Spiridon Papapetropoulos, Abraham Lieberman, Jocely Gonzalez, Carlos Singer, Daniel Z Laufer, Deborah C Mas. Family history of dementia: dementia with lewy bodies and dementia in Parkinson's disease. The Journal of neuropsychiatry and clinical neurosciences. vol 18. issue 1. 2006-05-26. PMID:16525079. |
parkinson's disease with dementia (pd-d) and dementia with lewy bodies (dlb) may result from the same neurodegenerative process with different temporal and spatial courses. |
2006-05-26 |
2023-08-12 |
Not clear |
| Spiridon Papapetropoulos, Abraham Lieberman, Jocely Gonzalez, Carlos Singer, Daniel Z Laufer, Deborah C Mas. Family history of dementia: dementia with lewy bodies and dementia in Parkinson's disease. The Journal of neuropsychiatry and clinical neurosciences. vol 18. issue 1. 2006-05-26. PMID:16525079. |
the authors report an association between dlb and family history of dementia in a comparison study between patients with a clinicopathological diagnosis of pd-d and dlb. |
2006-05-26 |
2023-08-12 |
Not clear |
| Spiridon Papapetropoulos, Abraham Lieberman, Jocely Gonzalez, Carlos Singer, Daniel Z Laufer, Deborah C Mas. Family history of dementia: dementia with lewy bodies and dementia in Parkinson's disease. The Journal of neuropsychiatry and clinical neurosciences. vol 18. issue 1. 2006-05-26. PMID:16525079. |
findings suggest that positive family history for dementia is associated with dlb with a yet unknown mechanism. |
2006-05-26 |
2023-08-12 |
Not clear |
| G Santpere, M Nieto, B Puig, I Ferre. Abnormal Sp1 transcription factor expression in Alzheimer disease and tauopathies. Neuroscience letters. vol 397. issue 1-2. 2006-05-25. PMID:16378688. |
sp1 transcription factor expression was examined by immunohistochemistry, immunofluorescence and confocal microscopy in alzheimer disease (ad), pick disease (pid), progressive supranuclear palsy (psp), parkinson disease (pd) and dementia with lewy bodies (dlb). |
2006-05-25 |
2023-08-12 |
Not clear |